ONE Bio Statistics
Total Valuation
ONE Bio has a market cap or net worth of 1,674.
| Market Cap | 1,674 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ONE Bio has 8.37 million shares outstanding.
| Current Share Class | 8.37M |
| Shares Outstanding | 8.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +8.76% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.57 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 1.66 |
| Debt / FCF | 2.36 |
| Interest Coverage | 11.38 |
Financial Efficiency
Return on equity (ROE) is 20.09% and return on invested capital (ROIC) is 13.92%.
| Return on Equity (ROE) | 20.09% |
| Return on Assets (ROA) | 12.53% |
| Return on Invested Capital (ROIC) | 13.92% |
| Return on Capital Employed (ROCE) | 29.57% |
| Revenue Per Employee | 150,583 |
| Profits Per Employee | 24,972 |
| Employee Count | 358 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 4.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -4.09 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ONE Bio had revenue of 53.91 million and earned 8.94 million in profits. Earnings per share was 1.22.
| Revenue | 53.91M |
| Gross Profit | 23.67M |
| Operating Income | 15.15M |
| Pretax Income | 12.87M |
| Net Income | 8.94M |
| EBITDA | 16.07M |
| EBIT | 15.15M |
| Earnings Per Share (EPS) | 1.22 |
Balance Sheet
The company has 14.46 million in cash and 26.62 million in debt, giving a net cash position of -12.16 million or -1.45 per share.
| Cash & Cash Equivalents | 14.46M |
| Total Debt | 26.62M |
| Net Cash | -12.16M |
| Net Cash Per Share | -1.45 |
| Equity (Book Value) | 49.75M |
| Book Value Per Share | 5.75 |
| Working Capital | 18.15M |
Cash Flow
In the last 12 months, operating cash flow was 14.73 million and capital expenditures -3.44 million, giving a free cash flow of 11.30 million.
| Operating Cash Flow | 14.73M |
| Capital Expenditures | -3.44M |
| Free Cash Flow | 11.30M |
| FCF Per Share | 1.35 |
Margins
Gross margin is 43.90%, with operating and profit margins of 28.11% and 16.58%.
| Gross Margin | 43.90% |
| Operating Margin | 28.11% |
| Pretax Margin | 23.87% |
| Profit Margin | 16.58% |
| EBITDA Margin | 29.80% |
| EBIT Margin | 28.11% |
| FCF Margin | 20.95% |
Dividends & Yields
ONE Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.04% |
| Buyback Yield | -15.87% |
| Shareholder Yield | -15.87% |
| Earnings Yield | 534,039.31% |
| FCF Yield | 674,820.55% |
Stock Splits
The last stock split was on September 15, 2010. It was a reverse split with a ratio of 0.2.
| Last Split Date | Sep 15, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ONE Bio has an Altman Z-Score of 2.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.58 |
| Piotroski F-Score | n/a |